Janssen Presents First Data from MajesTEC-2 Trial of TECVAYLI®▼ (teclistamab) in Combination with DARZALEX® (daratumumab) Subcutaneous (SC) Formulation and Lenalidomide in Relapsed or Refractory Multiple Myeloma Read more
Janssen Presents New Data for Talquetamab, a GPRC5DxCD3 Bispecific Antibody, Showing Durable Responses in Patients with Heavily Pretreated Multiple Myeloma Read more
The Partnership for a Drug-Free New Jersey Addresses Surging Substance Use-Related Deaths Among Older Adults Read more
SOC (Spin on Carbon) Hardmasks (COVID-19) to Witness Astonishing Growth by Forecast 2022-2030 | JC Market Research Read more
Comprehensive Report on Learning Management System in Education Market 2022 Trends, Growth Demand, Opportunities & Forecast To 2031 | JC Market Research Read more
Hybrid Rice Seeds Market 2022: Potential growth, attractive valuation make it is a long-term investment Know the COVID19 Impact | JC Market Research Read more